Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
RO.SW Stock Summary
Top 10 Correlated ETFs
RO.SW
In the News
RO.SW Financial details
Company Rating
Strong Buy
Market Cap
236.87B
Income
13.3B
Revenue
60.31B
Book val./share
-
Cash/share
-
Dividend
9.5
Dividend %
3.05%
Employees
103.61K
Optionable
No
Shortable
Yes
Earnings
23 Jul 2020
P/E
20.04
Forward P/E
-
PEG
-39.08
P/S
3.71
P/B
8.89
P/C
-
P/FCF
16.94
Quick Ratio
0.36
Current Ratio
1.24
Debt / Equity
2.01
LT Debt / Equity
0.8
-
-
EPS (TTM)
15.54
EPS next Y
-
EPS next Q
-
EPS this Y
-5.25%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
4.78%
Revenue last 5Y
2.17%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
2.74%
SMA50
10.68%
SMA100
-12.55%
Inst Own
0%
Inst Trans
0%
ROA
14%
ROE
47%
ROC
0.29%
Gross Margin
68%
Oper. Margin
28%
Profit Margin
20%
Payout
60%
Shs Outstand
754.49M
Shs Float
673.33M
-
-
-
-
Target Price
-
52W Range
267.0-409.6
52W High
-23.62%
52W Low
+17%
RSI
56.37
Rel Volume
-
Avg Volume
48.72K
Volume
128
Perf Week
-0.26%
Perf Month
5.75%
Perf Quarter
-16.74%
Perf Half Y
-17.53%
-
-
-
-
Beta
0.186073
-
-
Volatility
2.38%, 5.39%
Prev Close
0%
Price
312.4
Change
-0.26%
RO.SW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 66.56 | 71.81 | 68.21 | 73.88 | 79.1 | |
Net income per share | 12.3 | 15.77 | 16.72 | 16.39 | 15.53 | |
Operating cash flow per share | 23.39 | 26.15 | 21.71 | 24.68 | 23.02 | |
Free cash flow per share | 17.63 | 20.43 | 13.89 | 19.33 | 17.33 | |
Cash per share | 15.36 | 13.85 | 14.43 | 15.33 | 12.21 | |
Book value per share | 32.34 | 38.26 | 42.5 | 28.81 | 34.99 | |
Tangible book value per share | 14.14 | 17.59 | 21.65 | 6.38 | 14.39 | |
Share holders equity per share | 32.34 | 38.26 | 42.5 | 28.81 | 34.99 | |
Interest debt per share | 22.85 | 19.13 | 18.67 | 38.79 | 34.04 | |
Market cap | 204.45B | 263.31B | 265.05B | 347.48B | 286.72B | |
Enterprise value | 216.54B | 272.81B | 274.73B | 373.18B | 308.27B | |
P/E ratio | 19.47 | 19.51 | 18.54 | 24.94 | 23.08 | |
Price to sales ratio | 3.6 | 4.28 | 4.54 | 5.53 | 4.53 | |
POCF ratio | 10.23 | 11.76 | 14.28 | 16.57 | 15.57 | |
PFCF ratio | 13.58 | 15.06 | 22.32 | 21.15 | 20.68 | |
P/B Ratio | 7.4 | 8.04 | 7.29 | 14.19 | 10.24 | |
PTB ratio | 7.4 | 8.04 | 7.29 | 14.19 | 10.24 | |
EV to sales | 3.81 | 4.44 | 4.71 | 5.94 | 4.87 | |
Enterprise value over EBITDA | 11.92 | 12.55 | 12.21 | 16.32 | 14.32 | |
EV to operating cash flow | 10.84 | 12.19 | 14.8 | 17.79 | 16.74 | |
EV to free cash flow | 14.38 | 15.6 | 23.13 | 22.72 | 22.24 | |
Earnings yield | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | |
Free cash flow yield | 0.07 | 0.07 | 0.04 | 0.05 | 0.05 | |
Debt to equity | 1.74 | 1.44 | 1.28 | 2.61 | 2.01 | |
Debt to assets | 0.61 | 0.57 | 0.54 | 0.69 | 0.64 | |
Net debt to EBITDA | 0.67 | 0.44 | 0.43 | 1.12 | 1 | |
Current ratio | 1.4 | 1.3 | 1.3 | 0.93 | 1.24 | |
Interest coverage | 19.85 | 22.18 | 33.53 | 43.33 | 25.33 | |
Income quality | 1.84 | 1.59 | 1.23 | 1.4 | 1.36 | |
Dividend Yield | 0.04 | 0.03 | 0.03 | 0.02 | 0.03 | |
Payout ratio | 0.69 | 0.57 | 0.54 | 0.56 | 0.6 | |
Sales general and administrative to revenue | 0.09 | 0.07 | 0.05 | 0.05 | 0.05 | |
Research and developement to revenue | 0.21 | 0.21 | 0.22 | 0.24 | 0.25 | |
Intangibles to total assets | 0.23 | 0.25 | 0.25 | 0.25 | 0.23 | |
Capex to operating cash flow | -0.25 | -0.22 | -0.36 | -0.22 | -0.25 | |
Capex to revenue | -0.09 | -0.08 | -0.11 | -0.07 | -0.07 | |
Capex to depreciation | -1.37 | -1.14 | -1.47 | -1.02 | -1.18 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 94.59 | 116.5 | 126.45 | 103.07 | 110.56 | |
ROIC | 0.18 | 0.22 | 0.22 | 0.21 | 0.19 | |
Return on tangible assets | 0.17 | 0.22 | 0.22 | 0.2 | 0.18 | |
Graham Net | -37.15 | -37.78 | -35.6 | -55.39 | -52.58 | |
Working capital | 9.21B | 7.14B | 7.54B | -2.79B | 6.58B | |
Tangible asset value | 12.07B | 15.05B | 18.51B | 5.42B | 11.51B | |
Net current asset value | -15.91B | -15.97B | -13.42B | -28.35B | -22.32B | |
Invested capital | 0.68 | 0.48 | 0.42 | 1.33 | 0.95 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 2.82B | 3.01B | 3.25B | 3.58B | 3.85B | |
Average inventory | 7.01B | 6.34B | 6.62B | 7.45B | 8.16B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 60.17 | 63.17 | 74.84 | 71.41 | 69.09 | |
Days of inventory on hand | 139.94 | 120.43 | 162.32 | 143.33 | 153.98 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 6.07 | 5.78 | 4.88 | 5.11 | 5.28 | |
Inventory turnover | 2.61 | 3.03 | 2.25 | 2.55 | 2.37 | |
ROE | 0.38 | 0.41 | 0.39 | 0.57 | 0.44 | |
Capex per share | -5.76 | -5.72 | -7.82 | -5.35 | -5.69 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
Metric | History | 2020-12-31 | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 9.68B | 10.01B | 25.7B | 23.44B | 21.55B | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 1.28 | 1.23 | 2.61 | 2.29 | 2.01 | |
Debt to assets | 0.54 | 0.53 | 0.69 | 0.67 | 0.64 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 1.3 | 1.24 | 0.93 | 1.11 | 1.24 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.25 | 0.26 | 0.25 | 0.26 | 0.23 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 7.54B | 6.07B | -2.79B | 2.91B | 6.58B | |
Tangible asset value | 18.51B | 18.3B | 5.42B | 6.05B | 11.51B | |
Net current asset value | -13.42B | -15.19B | -28.35B | -27.47B | -22.32B | |
Invested capital | 0.42 | 0.4 | 1.33 | 1.1 | 0.95 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
RO.SW Frequently Asked Questions
What is Roche Holding AG stock symbol ?
Roche Holding AG is a CH stock and trading under the symbol RO.SW
What is Roche Holding AG stock quote today ?
Roche Holding AG stock price is $312.4 today.
Is Roche Holding AG stock public?
Yes, Roche Holding AG is a publicly traded company.